Skip to main content
Caplight Logo









Arog Pharmaceuticals

Arog Pharmaceuticals

Private
Dallas, TexasHealthcare & Life Scienceshttps://arogpharma.com/

Last Round

IPO

Sep 28, 2018

Company Overview

Arog Pharmaceuticals is a biopharmaceutical company that develops small molecule kinase inhibitors for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaloncologykinase inhibitorcrenolanibacute myeloid leukemiaAMLFLT3 inhibitortargeted therapygastrointestinal stromal tumorsGISTdrug discoveryclinical trialsmall molecule drugcancer drug developmentprecision medicinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arog Pharmaceuticals Comparables

Compare Arog Pharmaceuticals with similar companies based on industry and business-model similarity.

Arog Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hanmi Pharm Co Ltd
81%
Crescent Biopharma
77%
Astellas Pharma Inc.
75%

Arog Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOSep 28, 2018

Key People

Founding team and executive leadership

Amitkumar Patel

Chief Operating Officer

Executive Team

Arog Pharmaceuticals Investors

Notable investors and investment history

Arog Pharmaceuticals investors
InvestorRounds
Nomura SecuritiesIPO
RBC Capital MarketsIPO
CitigroupIPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 24, 2026

    Monthly visitors grew 304% MoM, reaching 3.8K.

  • Jul 19, 2025

    Grew 50% QoQ from 8 to 12 employees.

Arog Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Arog Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arog Pharmaceuticals's valuation, stock price, and market status.

Is Arog Pharmaceuticals a public or private company?

Arog Pharmaceuticals is a private company.

What is the current stock price of Arog Pharmaceuticals?

Arog Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Arog Pharmaceuticals worth (valuation)?

Valuation information for Arog Pharmaceuticals is not publicly available.

Can I buy Arog Pharmaceuticals stock?

Arog Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arog Pharmaceuticals's last funding round?

Arog Pharmaceuticals's most recent funding round was IPO on September 28, 2018.

Who are the main investors in Arog Pharmaceuticals?

Key investors in Arog Pharmaceuticals include Nomura Securities, RBC Capital Markets.

Will Arog Pharmaceuticals IPO soon?

No public IPO plans have been announced for Arog Pharmaceuticals.

How can I track Arog Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arog Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDallas, Texas
Employee Range11
Year Founded2010
Last FundingSep 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?